About us
Services
Science Hub
News & Events
Investors
Contact us
EN

Science News
Resources

GLP-1

FDA approves first medication for obstructive sleep apnea: Eli Lilly’s Zepbound GLP-1 agonist

The use of GLP-1 analogs is growing rapidly in obese and overweight patients who need to control body weight.

Huge spike in the use of GLP-1 analogs amid severe shortages

Contact

Find out how we may support your business.

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

By sending the contact form, I declare that I have read the privacy policy available at this link.

Privacy policy
Services
Investors
News&Events
Contact us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Powered by